Please see below for recent MSK publications in the New England Journal of Medicine and Lancet, as well as MSK, Hartford, and Lehigh publications in the Journal of Clinical Oncology:

MSK:

• Elective Cancer Surgery In COVID-19-Free Surgical Pathways During The SARS-Cov-2 Pandemic: An International, Multicenter, Comparative Cohort Study
  By: Glasbey, James C.; Nepogodiev, Dmitri; Simoes, Joana F. F.; et al.
  Group Author(s): COVIDSurg Collaborative
  JOURNAL OF CLINICAL ONCOLOGY Volume: 39 Issue: 1 Pages: 66-+ Published: JAN 1 2021


• Palbociclib With Adjuvant Endocrine Therapy In Early Breast Cancer (PALLAS): Interim Analysis Of A Multicentre, Open-Label, Randomised, Phase 3 Study
  By: Mayer, Erica L.; Dueck, Amylou C.; Martin, Miguel; et al.
  LANCET ONCOLOGY Volume: 22 Issue: 2 Pages: 212-222 Published: FEB 2021


• The Role Of Androgen Deprivation Therapy On The Clinical Course Of COVID-19 Infection In Men With Prostate Cancer.
  By: Patel, Vaibhav G.; Zhong, Xiaobo; Shah, Neil J.; et al.
  JOURNAL OF CLINICAL ONCOLOGY Volume: 39 Issue: 6 Supplement: S Meeting Abstract: 41 Published: FEB 20 2021


• Melflufen and Dexamethasone in Heavily Pretreated Relapsed and Refractory Multiple Myeloma
  By: Richardson, Paul G.; Oriol, Albert; Larocca, Alessandra; et al.
  Group Author(s): HORIZON OP-106 Investigators
  JOURNAL OF CLINICAL ONCOLOGY Volume: 39 Issue: 7 Pages: 757-+ Published: MAR 1 2021


• Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma
  By: Choueiri, T. K.; Powles, T.; Burotto, M.; et al.
  Group Author(s): CheckMate 9ER Investigators
  NEW ENGLAND JOURNAL OF MEDICINE Volume: 384 Issue: 9 Pages: 829-841 Published: MAR 4 2021


• Diffuse Large B-Cell Lymphoma
  By: Sehn, Laurie H.; Salles, Gilles
  NEW ENGLAND JOURNAL OF MEDICINE Volume: 384 Issue: 9 Pages: 842-858 Published: MAR 4 2021


• Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma
  By: Motzer, Robert; Alekseev, Boris; Rha, Sun-Young; et al.
  Group Author(s): CLEAR Trial Investigators
  NEW ENGLAND JOURNAL OF MEDICINE Volume: 384 Issue: 14 Pages: 1289-1300 Published: APR 8 2021

HHC:

• A Phase I Trial Of Chemoimmunotherapy Combining Bacillus Calmette-Guerin (BCG) And Intravesical Gemcitabine For Patients With BCG-Relapsing High-Grade Nonmuscle-Invasive Bladder Cancer
  By: Escano, De Jesus Manuel R.; Sjoberg, Daniel D.; McCarter, Melissa; et al.
  JOURNAL OF CLINICAL ONCOLOGY Volume: 39 Issue: 6 Supplement: S Meeting Abstract: TPS509 Published: FEB 20 2021

LVCI:

• Subgroup Analyses Of Patients (Pts) With Microsatellite Instability-High/Mismatch Repair-Deficient (MSI-H/Dmmr) Metastatic Colorectal Cancer (Mcrc) Treated With Nivolumab (NIVO) Plus Low-Dose Ipilimumab (IPI) As First-Line (1L) Therapy:Two-Year Clinical Update
  By: Lenz, Heinz-Josef; Lonardi, Sara; Zagonel, Vittorina; et al.
  JOURNAL OF CLINICAL ONCOLOGY Volume: 39 Issue: 3 Supplement: S Meeting Abstract: 58 Published: JAN 20 2021